The company's consistent ROCE and capital increase hint at a...
The company's consistent ROCE and capital increase hint at a lack of high return investments. High current liabilities to total assets ratio may pose risks. The stock's low return to shareholders over the past five years shows lackluster trends.
Return Trends At Shanghai Pharmaceuticals Holding (SHSE:601607) Aren't Appealing
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment